z-logo
open-access-imgOpen Access
Effectiveness at 24 Months of Single-Source Generic Carbamazepine, Lamotrigine, or Levetiracetam in Newly Diagnosed Focal Epilepsy
Author(s) -
Suresh Gurbani,
Sirichai Chayasirisobhon,
Aditya Gurbani,
Stephanie Tovar,
Erika Pietzsch,
Benjamin E. J. Spurgeon
Publication year - 2021
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/20.183
Subject(s) - medicine , levetiracetam , lamotrigine , carbamazepine , tolerability , adverse effect , epilepsy , rash , dosing , anesthesia , antiepileptic drug , lacosamide , pediatrics , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom